Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Indevr's AmpliPhox System

Premium

Indevr recently launched its AmpliPhox system for nucleic acid and protein microarray analysis.

AmpliPhox is based on Indevr's colorimetric detection technology. The approach relies on a photoinitiator that, when activated by light, generates signal amplification through polymerization of an organic monomer, according to the firm. The system's AmpliPhox Reader is used to activate photopolymerization on low-density arrays, to image the resulting pattern of visual spots, and automatically interpret the image.

The Boulder, Colo.-based company claims that results are delivered "within minutes" and are "visible to the naked eye."

Indevr claims that its detection technology, licensed from the University of Colorado, Boulder, enables it to offer the AmpliPhox Reader at "less than one-tenth the price of typical fluorescence microarray readers." The list price on the firm's website is $3,645. In comparison, ArrayIt advertises its SpotLight microarray scanner for $30,398.

Indevr CEO Kathy Rowlen said in a statement that the platform could be used for "a myriad of applications; everything from pathogen detection with nucleic acids to disease state profiling with proteins."

The company is currently offering free AmpliPhox systems to customers who purchase 10 reagent kits.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.